flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 in CKD - The (Journal Club Idol) Patients with type 2 #diabetes

Tirzepatide is a newer, physician-prescribed medication designed to support weight loss by targeting multiple metabolic pathways at once

(4) Metabolite synergy: BBR metabolites (berberrubine (BBB), palmatine (PMT)) reverse obesity-associated Akt pathway inhibition, ameliorating cell death, oxidative stress and mitochondrial dysfunction in HFD-fed mice [164]

Effects on glucose metabolism and weight are minimal and inconsistent

Before using Wegovy, talk with your doctor about your health history

For individuals who do well on phentermine but continue to battle with impulse eating, late night snacking, or emotional food choices, the addition of topiramate can produce meaningful improvements

Cancers 16 , 663 (2024)